214870 — NewGLab Pharma Co Cashflow Statement
0.000.00%
Last trade - 00:00
TechnologySpeculativeMicro Cap
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2,690 | -22,609 | -51,923 | -71,957 | 904 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1,600 | 7,101 | 27,711 | 47,633 | -12,859 |
Unusual Items | |||||
Purchased R&D | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -32,624 | -13,993 | 19,831 | 10,919 | -2,411 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -33,067 | -26,589 | 252 | -9,843 | -13,399 |
Capital Expenditures | -6,302 | -3,993 | -1,268 | -1,105 | -419 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 16,250 | -3,767 | -18,962 | -9,979 | 15,872 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 9,949 | -7,760 | -20,230 | -11,085 | 15,453 |
Financing Cash Flow Items | — | 6 | 7.2 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 51,564 | 35,562 | 8,278 | -5,092 | -8,480 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 28,380 | 855 | -11,162 | -26,019 | -6,335 |